Search This Blog

Monday, January 13, 2020

Illumina down 5% on weak 2020 outlook

Illumina (ILMN -4.8%) slips on below-average volume on the heels of CEO Francis deSouza’s presentation at JPMorgan’s Healthcare Conference.
He expects revenue growth of 9 – 11% this year, below consensus of 12%. Sequencing revenue should grow 14%.
#JPM20
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)